These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7906896)

  • 1. Phenylethylamine and schizophrenia.
    O'Reilly RL; Davis BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):63-75. PubMed ID: 7906896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylethylamine in neuropsychiatric disorders.
    Wolf ME; Mosnaim AD
    Gen Pharmacol; 1983; 14(4):385-90. PubMed ID: 6352395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
    Sabelli HC; Javaid JI
    J Neuropsychiatry Clin Neurosci; 1995; 7(1):6-14. PubMed ID: 7711493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics].
    Hirano M; Uchimura H; Shiraishi A; Kuroki T; Matsumoto T; Tsutsumi T
    Yakubutsu Seishin Kodo; 1989 Dec; 9(4):335-48. PubMed ID: 2698018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of beta-phenylethylamine, deuterated beta-phenylethylamine, phenylethanolamine and some metabolites of phenylethylamine in rodents.
    Reid D; Goudie AJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1547-53. PubMed ID: 3737623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
    Potkin SG; Wyatt RJ; Karoum F
    Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenylethylamine in paranoid chronic schizophrenia.
    Potkin SG; Karoum F; Chuang LW; Cannon-Spoor HE; Phillips I; Wyatt RJ
    Science; 1979 Oct; 206(4417):470-1. PubMed ID: 504988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phenylethylamine levels of schizophrenic patients.
    Shirkande S; O'Reilly R; Davis B; Durden D; Malcom D
    Can J Psychiatry; 1995 May; 40(4):221. PubMed ID: 7621397
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.
    Szymanski HV; Naylor EW; Karoum F
    Biol Psychiatry; 1987 Feb; 22(2):194-8. PubMed ID: 3814669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylacetic acid in CSF and serum in Indian schizophrenic patients.
    Davis BA; Shrikhande S; Paralikar VP; Hirsch SR; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):41-7. PubMed ID: 2008539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler".
    Semba J; Nankai M; Maruyama Y; Kaneno S; Watanabe A; Takahashi R
    J Nerv Ment Dis; 1988 Feb; 176(2):116-9. PubMed ID: 3339341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylethylamine excretion in depression.
    DeLisi LE; Murphy DL; Karoum F; Mueller E; Targum S; Wyatt RJ
    Psychiatry Res; 1984 Nov; 13(3):193-201. PubMed ID: 6597458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression during methadone withdrawal: no role for beta-phenylethylamine.
    Kaufmann CA; Kreek MJ; Karoum F; Chuang LW
    Drug Alcohol Depend; 1984 Jan; 13(1):21-9. PubMed ID: 6734421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum.
    Garver DL; Holcomb JA; Christensen JD
    J Clin Psychiatry; 2000 Dec; 61(12):964-72; quiz 973. PubMed ID: 11206608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.